Celebrating Excellence: Pfizer CentreOne wins the CDMO Leadership Awards 2024
How did Pfizer CentreOne perform this year?
As a leading global contract development & manufacturing organization (CDMO), integrated within Pfizer, Pfizer CentreOne (PC1) customer partnerships are the cornerstone of success. Leading to breakthroughs that profoundly impact patients lives.
For the eighth consecutive year, PC1’s unwavering commitment to quality and service has been recognized with the Outsourced Pharma & Life Science Leaders CDMO Leadership Awards. This prestigious honour is a testament to the trust and satisfaction of customers, as it is based entirely on their feedback.
This year, PC1 achieved an unprecedented level of distinction, being named category champion in all areas of the CDMO Leadership Awards:
• Capabilities
• Compatibility
• Expertise
• Quality
• Reliability
• Service
In addition, PC1 was lauded for exceeding customer expectations in Capabilities, Compatibility, Quality, Reliability, and Service, as well as earning individual awards for:
• Accessible to senior management
• Innovation
• On-time delivery
• Reputation
• Right first time
• State of the art
• Strength of science
PC1 remains committed to accelerating the drug development journey and bringing medicine to patients more swiftly - because time is life. PC1's continued recognition through the CDMO Leadership Awards is more than just an accolade; it is a reflection of PC1’s relentless pursuit of excellence and innovation.
A message from us to our customers
We extend our heartfelt thanks to all of our customers. We are deeply honoured that our team’s skills, dedication, and hard work have been recognized. Your feedback is invaluable to us, and we are truly grateful for your partnership.
We look forward to continuing our joint efforts to help accelerate your drug development journey and bring medicine to patients more quickly – because time is life.